Properdin homeostasis requires turnover of the alternative complement pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 45, 2010, Pages 19444-19448

  Wu, Xiaobo ^a   Xu, Thomas Q ^a   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C3; Innate immunity; Neutrophil; Regulators of complement activation

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR D; PROPERDIN; SNAKE VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; COMPLEMENT ALTERNATIVE PATHWAY; CONFERENCE PAPER; ENZYME ACTIVATION; HOMEOSTASIS; IMMUNE COMPLEX DEPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TURNOVER TIME;

MUS;

EID: 78650595289     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006608107     Document Type: Article

References (46)

1. Müller-Eberhard HJ (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57:321-347.
2. Lachmann PJ (2009) The amplification loop of the complement pathways. Adv Immunol 104:115-149.
3. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 61:201-283.
4. Pillemer L, et al. (1954) The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120:279-285.
5. Fearon DT, Austen KF (1975) Properdin: Binding to C3b and stabilization of the C3bdependent C3 convertase. J Exp Med 142:856-863.
6. Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE (2007) Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179:2600-2608.
7. Kemper C, Mitchell LM, Zhang L, Hourcade DE (2008) The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA 105:9023-9028.
8. Xu W, et al. (2008) Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol 180: 7613-7621.
9. Kimura Y, Miwa T, Zhou L, Song WC (2008) Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111:732-740.
10. Kemper C, Atkinson JP, Hourcade DE (2010) Properdin: Emerging roles of a patternrecognition molecule. Annu Rev Immunol 28:131-155.
11. Alper CA, Abramson N, Johnston RB, Jr., Jandl JH, Rosen FS (1970) Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest 49:1975-1985.
12. Ziegler JB, Alper CA, Rosen RS, Lachmann PJ, Sherington L (1975) Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency. J Clin Invest 55:668-672.
13. Lopez-Larrea C, et al. (1987) A familial deficiency of complement factor H. Biochem Soc Trans 15:648-649.
14. Levy M, et al. (1986) H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 30:949-956.
15. Thompson RA, Winterborn MH (1981) Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol 46:110-119.
16. Pickering MC, et al. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31:424-428.
17. Høgåsen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995) Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95:1054-1061.
18. Wu X, et al. (2008) Membrane protein Crry maintains homeostasis of the complement system. J Immunol 181:2732-2740.
19. Ruseva MM, et al. (2009) Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. Mol Immunol 46:803-811.
20. Miwa T, et al. (2007) DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity. Mol Immunol 44:139-146.
21. Schwaeble W, et al. (1993) Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J Immunol 151: 2521-2528.
22. Schwaeble W, et al. (1994) Expression of properdin in human monocytes. Eur J Biochem 219:759-764.
23. Farries TC, Atkinson JP (1989) Biosynthesis of properdin. J Immunol 142:842-847.
24. Wirthmueller U, et al. (1997) Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 158:4444-4451.
25. Wong WW, Fearon DT (1985) p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J Immunol 134:4048-4056.
26. Kim YU, et al. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181:151-159.
27. Xu C, et al. (2000) A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287:498-501.
28. Mao D, et al. (2003) Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19:813-822.
29. Kohler PF, Müller-Eberhard HJ (1969) Complement-immunoglobulin relation: Deficiency of C'1q associated with impaired immunoglobulin G synthesis. Science 163: 474-475.
30. Kohler PF, Müller-Eberhard HJ (1972) Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. J Clin Invest 51:868-875.
31. Atkinson JP, Fisher FI, Reinhardt R, Frank MM (1978) Reduced concentrations of the first component of complement in hypotammaglobulinemia: Correction of infusion of gamma-globulin. Clin Immunol Immunopathol 9:350-355.
32. Goundis D, Holt SM, Boyd Y, Reid KB (1989) Localization of the properdin structural locus to Xp11.23-Xp21.1. Genomics 5:56-60.
33. Matsumoto M, et al. (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 94:8720-8725.
34. Xu Y, et al. (2001) Complement activation in factor D-deficient mice. Proc Natl Acad Sci USA 98:14577-14582.
35. Wu X, et al. (2000) Impaired affinity maturation in Cr2-/-mice is rescued by adjuvants without improvement in germinal center development. J Immunol 165:3119-3127.
36. Drouin SM, et al. (2001) Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166:2025-2032.
37. Ganu VS, Müller-Eberhard HJ, Hugli TE (1989) Factor C3f is a spasmogenic fragment released from C3b by factors I and H: The heptadeca-peptide C3f was synthesized and characterized. Mol Immunol 26:939-948.
38. Xiang Y, et al. (2007) Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: Complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells. Arthritis Rheum 56:2018-2030.
39. Riley-Vargas RC, Lanzendorf S, Atkinson JP (2005) Targeted and restricted complement activation on acrosome-reacted spermatozoa. J Clin Invest 115:1241-1249.
40. Haas PJ, van Strijp J (2007) Anaphylatoxins: Their role in bacterial infection and inflammation. Immunol Res 37:161-175.
41. Ferreira VP, Cortes C, Pangburn MK (2010) Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement. Immunobiology 215:932-940.
42. Circolo A, et al. (1999) Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42:135-149.
43. Wessels MR, et al. (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 92:11490-11494.
44. Botto M, et al. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56-59.
45. Sun X, et al. (1999) Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci USA 96:628-633.
46. Molina H, et al. (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93:3357-3361.